n-Butyl-2-cyanoacrylate (0.25ml)

Clinical Pharmacologist's Monograph

⚠️ Prescription Only: This medicine is Schedule H/H1. Do not self-medicate.

1. Clinical Overview

n-Butyl-2-cyanoacrylate (NBCA) is a liquid embolic agent and tissue adhesive belonging to the cyanoacrylate class. It is a monomer that undergoes rapid anionic polymerization upon contact with ionic substances (e.g., blood, tissue fluids), forming a solid, flexible, and histotoxic polymer. In the Indian clinical context, it is primarily used for endoscopic and interventional radiological procedures to achieve hemostasis and embolization. The 0.25ml presentation is a common single-use volume for precise application.

OnsetDurationBioavailability
2-5 seconds (polymerization time upon contact with anionic medium).The polymer is permanent and non-biodegradable; it remains at the application site indefinitely, although it may slough off mucosal surfaces over weeks as tissue heals underneath.Not applicable (N/A). It is a topical/embolic agent with no systemic absorption when used correctly.

2. Mechanism of Action

NBCA is a liquid monomer that polymerizes rapidly and exothermically in the presence of anions (hydroxyl ions from water, blood, tissue fluids). This polymerization forms long, strong chains, creating a solid cast that mechanically occludes blood vessels (embolization) or seals tissue appositions (adhesion). It also induces a significant inflammatory reaction, leading to fibrosis and permanent vessel occlusion.

3. Indications & Uses

  • Endoscopic cyanoacrylate injection for gastric variceal bleeding (GOV1, IGV1).
  • Pre-operative or palliative embolization of hypervascular tumors (e.g., renal cell carcinoma).
  • Embolization of cerebral arteriovenous malformations (AVMs) and fistulas.
  • Embolization of acute non-variceal arterial hemorrhage (e.g., traumatic, GI).

4. Dosage & Administration

Adult Dosage: Dose is NOT based on body weight. It is procedure and target-specific. For gastric varices: Typically 0.5ml to 2.0ml per varix, administered in 0.25ml to 0.5ml aliquots per injection session. The 0.25ml volume allows for precise, controlled injection.

Administration: FOR TRAINED SPECIALISTS ONLY. Must be mixed with an oil-based contrast agent (e.g., Ethiodized Oil/Lipiodol) in ratios from 1:1 to 1:4 (NBCA:Lipiodol) to slow polymerization for controlled delivery. Use non-ionic solutions (e.g., 5% dextrose) to flush catheters/needles BEFORE administration to prevent premature polymerization. Delivered via specialized catheters/needles (e.g., sclerotherapy needle) under endoscopic or fluoroscopic guidance. Rapid withdrawal of delivery system is critical after injection to avoid adherence.

5. Side Effects

Common side effects may include:

  • Transient fever (post-embolization syndrome).
  • Local pain at injection/application site.
  • Inflammatory reaction with redness and swelling.
  • Nausea and vomiting (especially post-procedural).

6. Drug Interactions

DrugEffectSeverity
Anticoagulants (Warfarin, DOACs) & Antiplatelets (Clopidogrel, Aspirin)Increased risk of procedural hemorrhage. Interaction is procedural, not pharmacological.Major
Iodinated Contrast Media (ionic)If mixed directly, causes instantaneous, uncontrolled polymerization, ruining the procedure and risking catheter adherence.Major
Alcohol (used for sclerotherapy)Not to be used in the same session with NBCA. Can alter polymerization and increase tissue necrosis risk.Moderate

7. Patient Counselling

  • Do follow all pre-procedure fasting instructions.
  • Do inform your doctor of all allergies, especially to acrylics, and all medications (blood thinners).
  • Do not expect the 'glue' to be removed; it is designed to stay in place.
  • Do report any fever, severe pain, chest pain, shortness of breath, or neurological symptoms immediately after the procedure.

8. Toxicology & Storage

Overdose: Overdose' refers to injection of an excessive volume leading to: 1) Nontarget embolization (pulmonary, cerebral, systemic) causing infarction. 2) Extensive local tissue necrosis. 3) Vessel rupture from over-distension.

Storage: Store in a cool, dry place. Protect from moisture. The vial should be kept in its original packaging until use. Do not refrigerate or freeze. Shelf life is typically 2-3 years from manufacture. Once opened, the vial is for single use only and any unused portion must be discarded. Do not use if the liquid appears cloudy or has solidified.